Table 2.
Comparison of baseline characteristics between RT-lesions and VT-lesions
| VT-lesions | RT-lesions | p value | |
|---|---|---|---|
| No. of HCC lesions | 72 | 20 | – |
| Age (range) | 71.7 (49–87) | 65.3 (49–88) | 0.03* |
| Gender (%) | |||
| Women | 15 (20.8) | 2 (10) | 0.27 |
| Men | 57 (79.2) | 18 (90) | |
| Cirrhosis (%) | |||
| Yes | 60 (83.3) | 20 (100) | < 0.001* |
| No | 12 (16.7) | 0 (0) | |
| BCLC stage (%) | |||
| A | 38 (52.8) | 10 (50) | 0.83 |
| B | 34 (47.2) | 10 (50) | |
| No. of HCC lesions per patient | 2.7 (1–7) | 1.7 (1–4) | < 0.001* |
| Follow-up after TACE in days (SD) | 268 (± 235) | 171 (± 110) | < 0.001* |
| I | 1 (1.4) | 0 (0) | |
| II | 10 (13.9) | 0 (0) | |
| III | 2 (2.8) | 0 (0) | |
| IVa | 5 (6.9) | 3 (15) | |
| IVb | 4 (5.6) | 0 (0) | |
| Liver segment (%) | |||
| Left lobe | 22 (30.6) | 3 (15) | 0.03* |
| V | 11 (15.3) | 3 (15) | |
| VI | 8 (11.1) | 0 (0) | |
| VII | 13 (18.1) | 1 (5) | |
| VIII | 18 (25.0) | 13 (65) | |
| Right lobe | 50 (69.4) | 17 (85) | |
| Area in mm2 (SD) | 1062.8 (± 2308.6) | 789.9 (± 1167.2) | 0.61 |
| Long axis in mm (SD) | 33.9 (± 28.6) | 36.9 (± 26.9) | 0.68 |
| MPP (SD) | 180.5 (± 213.6) | 92.8 (± 21.6) | 0.001* |
| Entropy (SD) | 6.084 (± 0.55) | 5.934 (± 0.79) | 0.33 |
| Kurtosis (SD) | 3.3 (± 1.1) | 3.4 (± 1.0) | 0.72 |
| Skewness (SD) | − 0.1 (± 0.35) | − 0.1 (± 0.4) | 0.42 |
| Uniformity (SD) | 0.0184 (± 0.008) | 0.0222 (± 0.015) | 0.31 |
Statistically significant differences are marked by an asterisk
VT-lesions lesions undergoing primary TACE, RT-lesions lesions undergoing repeated TACE, SD standard deviation, TACE transcatheter arterial chemoembolization